Description
Pirfenidone works by downregulating the production of growth factors and procollagens that drive lung tissue scarring. It specifically inhibits the synthesis of transforming growth factor beta (TGF-beta), a key molecular driver of fibrogenesis. By suppressing this inflammatory cascade, the drug significantly slows the decline of forced vital capacity in patients.
User Reviews
Log in to leave a review.
No reviews yet for this remedy.